martes, 14 de junio de 2022

Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis | PLOS ONE

Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis | PLOS ONE

No hay comentarios:

Publicar un comentario